J. Goldman & CO LP Milestone Pharmaceuticals Inc. Transaction History
J. Goldman & CO LP
- $3.21 Billion
- Q3 2024
Shares
3 transactions
Others Institutions Holding MIST
# of Institutions
47Shares Held
27.9MCall Options Held
200Put Options Held
0-
Black Rock Inc. New York, NY4.97MShares$11.3 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.26MShares$7.39 Million0.08% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.78MShares$6.31 Million0.0% of portfolio
-
Alta Fundamental Advisers LLC New York, NY2.66MShares$6.03 Million1.79% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.06MShares$4.68 Million0.0% of portfolio
About Milestone Pharmaceuticals Inc.
- Ticker MIST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,010,900
- Market Cap $68.1M
- Description
- Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...